{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:02:41Z","timestamp":1793246561307,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01667-x","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:02:50Z","timestamp":1777021370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["DeepDrugDiscovery identifies blood\u2013brain barrier permeable autophagy enhancers for Alzheimer\u2019s disease"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4836-018X","authenticated-orcid":false,"given":"Yu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8648-6245","authenticated-orcid":false,"given":"Xianglu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2938-5923","authenticated-orcid":false,"given":"Xu-Xu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2911-9359","authenticated-orcid":false,"given":"Wen-Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Hang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3074-2411","authenticated-orcid":false,"given":"Shenglong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6477-7341","authenticated-orcid":false,"given":"Krinos","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangzhen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-2700","authenticated-orcid":false,"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanxing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-2617","authenticated-orcid":false,"given":"Jian-Bo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-8154","authenticated-orcid":false,"given":"Keqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro F.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-5235","authenticated-orcid":false,"given":"Chris Soon Heng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-7733","authenticated-orcid":false,"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7009-946X","authenticated-orcid":false,"given":"Zhangming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1147-125X","authenticated-orcid":false,"given":"Jia-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"1667_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBDDF Collaborators.","year":"2022","unstructured":"GBDDF Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105\u2013e125 (2022).","journal-title":"Lancet Public Health"},{"key":"1667_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct. Target. Ther. 9, 211 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1667_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman, Y. et al. Autophagy in healthy aging and disease. Nat. Aging 1, 634\u2013650 (2021).","journal-title":"Nat. Aging"},{"key":"1667_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon, R. A. & Rubinsztein, D. C. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 25, 926\u2013946 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1667_CR5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.24272\/j.issn.2095-8137.2023.294","volume":"44","author":"XW Zhang","year":"2023","unstructured":"Zhang, X. W. et al. Targeting autophagy in Alzheimer\u2019s disease: animal models and mechanisms. Zool. Res. 44, 1132\u20131145 (2023).","journal-title":"Zool. Res."},{"key":"1667_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","volume":"40","author":"JS Kerr","year":"2017","unstructured":"Kerr, J. S. et al. Mitophagy and Alzheimer\u2019s disease: cellular and molecular mechanisms. Trends Neurosci. 40, 151\u2013166 (2017).","journal-title":"Trends Neurosci."},{"key":"1667_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101307","volume":"67","author":"A Kobro-Flatmoen","year":"2021","unstructured":"Kobro-Flatmoen, A. et al. Re-emphasizing early Alzheimer\u2019s disease pathology starting in select entorhinal neurons, with a special focus on mitophagy. Ageing Res. Rev. 67, 101307 (2021).","journal-title":"Ageing Res. Rev."},{"key":"1667_CR8","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.apsb.2021.12.009","volume":"12","author":"Z Deng","year":"2022","unstructured":"Deng, Z. et al. Pharmacological modulation of autophagy for Alzheimer\u2019s disease therapy: opportunities and obstacles. Acta Pharm. Sin. B 12, 1688\u20131706 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"1667_CR9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.98649","volume":"13","author":"Y Date","year":"2024","unstructured":"Date, Y. et al. Novel autophagy inducers by accelerating lysosomal clustering against Parkinson\u2019s disease. eLife 13, e98649 (2024).","journal-title":"eLife"},{"key":"1667_CR10","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1042\/BST20130134","volume":"41","author":"S Sarkar","year":"2013","unstructured":"Sarkar, S. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. Biochem. Soc. Trans. 41, 1103\u20131130 (2013).","journal-title":"Biochem. Soc. Trans."},{"key":"1667_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/15548627.2019.1704119","volume":"16","author":"Y Dong","year":"2020","unstructured":"Dong, Y. et al. Autophagy modulator scoring system: a user-friendly tool for quantitative analysis of methodological integrity of chemical autophagy modulator studies. Autophagy 16, 195\u2013202 (2020).","journal-title":"Autophagy"},{"key":"1667_CR12","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.7150\/ijbs.97669","volume":"20","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Heterophyllin B enhances transcription factor EB-mediated autophagy and alleviates pyroptosis and oxidative stress after spinal cord injury. Int. J. Biol. Sci. 20, 5415\u20135435 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"1667_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams, A. et al. Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295\u2013305 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"1667_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4161\/auto.27710","volume":"10","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy 10, 588\u2013602 (2014).","journal-title":"Autophagy"},{"key":"1667_CR15","doi-asserted-by":"crossref","unstructured":"Mak, K. K. et al. Artificial intelligence in Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays (eds Franz, J. H. & Michael, K.) 1461\u20131498 (Springer, 2024).","DOI":"10.1007\/978-3-031-35529-5_92"},{"key":"1667_CR16","first-page":"2667","volume":"5","author":"AU Rehman","year":"2024","unstructured":"Rehman, A. U. et al. Role of artificial intelligence in revolutionizing drug discovery. Fundam. Res. 5, 2667\u20133258 (2024).","journal-title":"Fundam. Res."},{"key":"1667_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103665","volume":"28","author":"YZ Niu","year":"2023","unstructured":"Niu, Y. Z. & Lin, P. Advances of computer-aided drug design (CADD) in the development of anti-Azheimer\u2019s-disease drugs. Drug Discov. Today 28, 103665 (2023).","journal-title":"Drug Discov. Today"},{"key":"1667_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52061-7","volume":"15","author":"G Zhou","year":"2024","unstructured":"Zhou, G. et al. An artificial intelligence accelerated virtual screening platform for drug discovery. Nat. Commun. 15, 7761 (2024).","journal-title":"Nat. Commun."},{"key":"1667_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","volume":"31","author":"K Zhang","year":"2025","unstructured":"Zhang, K. et al. Artificial intelligence in drug development. Nat. Med. 31, 45\u201359 (2025).","journal-title":"Nat. Med."},{"key":"1667_CR20","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1016\/j.apsb.2023.07.016","volume":"13","author":"H Xiang","year":"2023","unstructured":"Xiang, H. et al. Drug discovery by targeting the protein-protein interactions involved in autophagy. Acta Pharm. Sin. B 13, 4373\u20134390 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"1667_CR21","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","volume":"119","author":"X Yang","year":"2019","unstructured":"Yang, X. et al. Concepts of artificial intelligence for computer-assisted drug discovery. Chem. Rev. 119, 10520\u201310594 (2019).","journal-title":"Chem. Rev."},{"key":"1667_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s42256-020-00285-9","volume":"3","author":"TH Pham","year":"2021","unstructured":"Pham, T. H. et al. A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing. Nat. Mach. Intell. 3, 247\u2013257 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"1667_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","volume":"6","author":"C Xie","year":"2022","unstructured":"Xie, C. et al. Amelioration of Alzheimer\u2019s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat. Biomed. Eng. 6, 76\u201393 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1667_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy research. Cell 140, 313\u2013326 (2010).","journal-title":"Cell"},{"key":"1667_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4161\/auto.1.2.1697","volume":"1","author":"I Tanida","year":"2005","unstructured":"Tanida, I. et al. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1, 84\u201391 (2005).","journal-title":"Autophagy"},{"key":"1667_CR26","doi-asserted-by":"publisher","first-page":"e2571","DOI":"10.21769\/BioProtoc.2571","volume":"7","author":"R Marwaha","year":"2017","unstructured":"Marwaha, R. & Sharma, M. DQ-Red BSA trafficking assay in cultured cells to assess cargo delivery to lysosomes. Bio Protoc. 7, e2571 (2017).","journal-title":"Bio Protoc."},{"key":"1667_CR27","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.7150\/ijbs.71041","volume":"18","author":"Y Dong","year":"2022","unstructured":"Dong, Y. et al. Toosendanin, a novel potent vacuolar-type H+-translocating ATPase inhibitor, sensitizes cancer cells to chemotherapy by blocking protective autophagy. Int. J. Biol. Sci. 18, 2684\u20132702 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"1667_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang, Y. & Mandelkow, E. Tau in physiology and pathology. Nat. Rev. Neurosci. 17, 5\u201321 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"1667_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson, T. et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488, 96\u201399 (2012).","journal-title":"Nature"},{"key":"1667_CR30","unstructured":"DeLoach, K. E. Characterization of Mice Expressing APPSwe\/Ind in DG, CA3 or CA1 of the Hippocampus. MSc thesis, UC San Diego (2012)."},{"key":"1667_CR31","first-page":"84","volume":"1","author":"Z Cai","year":"2013","unstructured":"Cai, Z. & Yan, L. J. Rapamycin, autophagy, and Alzheimer\u2019s disease. J. Biochem. Pharmacol. Res. 1, 84\u201390 (2013).","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"1667_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang, E. F. et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat. Neurosci. 22, 401\u2013412 (2019).","journal-title":"Nat. Neurosci."},{"key":"1667_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/15548627.2015.1033601","volume":"11","author":"B Pasquier","year":"2015","unstructured":"Pasquier, B. SAR405, a PIK3C3\/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells. Autophagy 11, 725\u2013726 (2015).","journal-title":"Autophagy"},{"key":"1667_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1247\/csf.23.33","volume":"23","author":"A Yamamoto","year":"1998","unstructured":"Yamamoto, A. et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23, 33\u201342 (1998).","journal-title":"Cell Struct. Funct."},{"key":"1667_CR35","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1021\/acschemneuro.7b00361","volume":"8","author":"EF Griffin","year":"2017","unstructured":"Griffin, E. F., Caldwell, K. A. & Caldwell, G. A. Genetic and pharmacological discovery for Alzheimer\u2019s disease using Caenorhabditis elegans. ACS Chem. Neurosci. 8, 2596\u20132606 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"1667_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102250","volume":"4","author":"SQ Cao","year":"2023","unstructured":"Cao, S. Q. et al. Chemotaxis assay for evaluation of memory-like behavior in wild-type and Alzheimer\u2019s-disease-like C. elegans models. STAR Protoc. 4, 102250 (2023).","journal-title":"STAR Protoc."},{"key":"1667_CR37","doi-asserted-by":"publisher","first-page":"e0204436","DOI":"10.1371\/journal.pone.0204436","volume":"13","author":"BH Strand","year":"2018","unstructured":"Strand, B. H. et al. Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway. PLoS ONE 13, e0204436 (2018).","journal-title":"PLoS ONE"},{"key":"1667_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","volume":"140","author":"EB Larson","year":"2004","unstructured":"Larson, E. B. et al. Survival after initial diagnosis of Alzheimer disease. Ann. Intern. Med. 140, 501\u2013509 (2004).","journal-title":"Ann. Intern. Med."},{"key":"1667_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","volume":"1348","author":"R Sterniczuk","year":"2010","unstructured":"Sterniczuk, R. et al. Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: part 1. Circadian changes. Brain Res. 1348, 139\u2013148 (2010).","journal-title":"Brain Res."},{"key":"1667_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2010.06.011","volume":"1348","author":"R Sterniczuk","year":"2010","unstructured":"Sterniczuk, R. et al. Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: part 2. Behavioral and cognitive changes. Brain Res. 1348, 149\u2013155 (2010).","journal-title":"Brain Res."},{"key":"1667_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.95412","volume":"13","author":"F Michaud","year":"2024","unstructured":"Michaud, F. et al. Altered firing output of VIP interneurons and early dysfunctions in CA1 hippocampal circuits in the 3xTg mouse model of Alzheimer\u2019s disease. eLife 13, RP95412 (2024).","journal-title":"eLife"},{"key":"1667_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111631","volume":"28","author":"S Park","year":"2025","unstructured":"Park, S. et al. Distinct disruptions in CA1 and CA3 place cell function in Alzheimer\u2019s disease mice. iScience 28, 111631 (2025).","journal-title":"iScience"},{"key":"1667_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.688090","volume":"15","author":"B Hussain","year":"2021","unstructured":"Hussain, B., Fang, C. & Chang, J. Blood-brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia. Front. Neurosci. 15, 688090 (2021).","journal-title":"Front. Neurosci."},{"key":"1667_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46630-z","volume":"15","author":"S Tsartsalis","year":"2024","unstructured":"Tsartsalis, S. et al. A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer\u2019s disease. Nat. Commun. 15, 2243 (2024).","journal-title":"Nat. Commun."},{"key":"1667_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1602\/neurorx.2.1.54","volume":"2","author":"A Tsuji","year":"2005","unstructured":"Tsuji, A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx 2, 54\u201362 (2005).","journal-title":"NeuroRx"},{"key":"1667_CR46","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s11095-007-9374-5","volume":"24","author":"S Ohtsuki","year":"2007","unstructured":"Ohtsuki, S. & Terasaki, T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res. 24, 1745\u20131758 (2007).","journal-title":"Pharm. Res."},{"key":"1667_CR47","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nprot.2015.101","volume":"10","author":"H Franken","year":"2015","unstructured":"Franken, H. et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat. Protoc. 10, 1567\u20131593 (2015).","journal-title":"Nat. Protoc."},{"key":"1667_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"1667_CR49","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: a free online platform for data visualization and graphing. PLoS ONE 18, e0294236 (2023).","journal-title":"PLoS ONE"},{"key":"1667_CR50","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1667_CR51","doi-asserted-by":"crossref","unstructured":"Passaro, S. et al. Boltz-2: towards accurate and efficient binding affinity prediction. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2025.06.14.659707v1 (2025).","DOI":"10.1101\/2025.06.14.659707"},{"key":"1667_CR52","doi-asserted-by":"publisher","first-page":"E051223224198","DOI":"10.2174\/0129503752250813231124092946","volume":"2","author":"P Bhatt","year":"2024","unstructured":"Bhatt, P. et al. Artificial intelligence in pharmaceutical industry: revolutionizing drug development and delivery. Curr. Artif. Intell. 2, E051223224198 (2024).","journal-title":"Curr. Artif. Intell."},{"key":"1667_CR53","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2174\/0115680266324522240725053634","volume":"25","author":"C Aundhia","year":"2025","unstructured":"Aundhia, C. et al. Impact of artificial intelligence on drug development and delivery. Curr. Top. Med. Chem. 25, 1165\u20131184 (2025).","journal-title":"Curr. Top. Med. Chem."},{"key":"1667_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13321-023-00703-1","volume":"15","author":"S Jung","year":"2023","unstructured":"Jung, S., Vatheuer, H. & Czodrowski, P. VSFlow: an open-source ligand-based virtual screening tool. J. Cheminform. 15, 40 (2023).","journal-title":"J. Cheminform."},{"key":"1667_CR55","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1021\/acs.jcim.4c00136","volume":"64","author":"B Ni","year":"2024","unstructured":"Ni, B. et al. AutoDock-SS: AutoDock for multiconformational ligand-based virtual screening. J. Chem. Inf. Model. 64, 3779\u20133789 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"1667_CR56","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10822-019-00236-6","volume":"33","author":"AE Cleves","year":"2019","unstructured":"Cleves, A. E., Johnson, S. R. & Jain, A. N. Electrostatic-field and surface-shape similarity for virtual screening and pose prediction. J. Comput. Aided Mol. Des. 33, 865\u2013886 (2019).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"1667_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/jm0603365","volume":"50","author":"PC Hawkins","year":"2007","unstructured":"Hawkins, P. C., Skillman, A. G. & Nicholls, A. Comparison of shape-matching and docking as virtual screening tools. J. Med. Chem. 50, 74\u201382 (2007).","journal-title":"J. Med. Chem."},{"key":"1667_CR58","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1021\/ci300601q","volume":"53","author":"X Yan","year":"2013","unstructured":"Yan, X. et al. Enhancing molecular shape comparison by weighted Gaussian functions. J. Chem. Inf. Model. 53, 1967\u20131978 (2013).","journal-title":"J. Chem. Inf. Model."},{"key":"1667_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37908-6","volume":"9","author":"S Puertas-Martin","year":"2019","unstructured":"Puertas-Martin, S. et al. OptiPharm: an evolutionary algorithm to compare shape similarity. Sci. Rep. 9, 1398 (2019).","journal-title":"Sci. Rep."},{"key":"1667_CR60","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/jcc.20681","volume":"28","author":"PJ Ballester","year":"2007","unstructured":"Ballester, P. J. & Richards, W. G. Ultrafast shape recognition to search compound databases for similar molecular shapes. J. Comput. Chem. 28, 1711\u20131723 (2007).","journal-title":"J. Comput. Chem."},{"key":"1667_CR61","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu, L. et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 52, W422\u2013W431 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1667_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"1667_CR63","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gkae298","volume":"52","author":"Y Gu","year":"2024","unstructured":"Gu, Y. et al. admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties. Nucleic Acids Res. 52, W432\u2013W438 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1667_CR64","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"1667_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/cells6020014","volume":"6","author":"M Moulis","year":"2017","unstructured":"Moulis, M. & Vindis, C. Methods for measuring autophagy in mice. Cells 6, 14 (2017).","journal-title":"Cells"},{"key":"1667_CR66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fnmol.2019.00203","volume":"12","author":"J Liu","year":"2019","unstructured":"Liu, J. & Li, L. Targeting autophagy for the treatment of Alzheimer\u2019s disease: challenges and opportunities. Front. Mol. Neurosci. 12, 203 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"1667_CR67","doi-asserted-by":"crossref","unstructured":"Choo, M. Z. Y. & Chai, C. L. L. The polypharmacology of natural products in drug discovery and development. Annual Reports in Medicinal Chemistry (ed. Karl-Heinz, A.) Vol. 61, 55\u2013100 (Elsevier, 2023).","DOI":"10.1016\/bs.armc.2023.10.002"},{"key":"1667_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105859","volume":"180","author":"R Naskar","year":"2024","unstructured":"Naskar, R. et al. A critical appraisal of geroprotective activities of flavonoids in terms of their bio-accessibility and polypharmacology. Neurochem. Int. 180, 105859 (2024).","journal-title":"Neurochem. Int."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01667-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01667-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01667-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:02:53Z","timestamp":1777021373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01667-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":68,"alternative-id":["1667"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01667-x","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.F.F. is a co-owner of Fang-S Consultation AS (organization number 931 410 717) and NO-Age AS (organization number 933 219 127); he has an MTA with LMITO Therapeutics Inc., a CRADA arrangement with ChromaDex, a commercialization agreement with Molecule AG\/VITADAO, and MTAs with GeneHarbor (Hong Kong) Biotechnologies Limited and Hong Kong Longevity Science Laboratory; he is a consultant to MindRank AI, NYO3, AgeLab (Vitality Nordic AS) and Hong Kong Longevity Science Laboratory. Z.N., X.X., W.W., W.J., C.M., X.J., Q.C. and S.D. are employers of MindRank AI.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}